Purpose <p>Time restricted eating (TRE) improves cardiometabolic (CM) health. However, TRE’s usefulness as a preventative intervention, particularly among women at risk for dysregulated eating is unknown. This single-arm study examined the impact of a 4-week TRE intervention on eating behaviors, body composition, and dietary intake in women at risk for dysregulated eating.</p> Methods <p>36 emerging adult women with eating windows ≥ 12&#xa0;h and moderate–high dietary restraint completed 1 baseline week and 4&#xa0;weeks of TRE (10&#xa0;h eating window ending by 8&#xa0;pm). Participants completed the Dutch Eating Behavior Questionnaire, 3-day food logs, anthropometric measurements, and DXA scans at baseline and post-intervention. Ecological momentary assessments (EMA) were administered 5x/day during baseline and weeks 1 and 4 of TRE to assess eating in the absence of hunger (EAH).</p> Results <p>Adherence with TRE and EMA was above 85%. Significant decreases occurred in emotional eating (<i>p</i> = 0.009, Cohen’s <i>d</i> = − 0.470), caloric intake (<i>p</i> &lt; 0.001, Cohen’s<i> d</i> = − 0.750), body weight (<i>p</i> &lt; 0.001, Cohen’s <i>d</i> = − 0.649), and visceral fat (<i>p</i> = 0.026, Cohen’s <i>d</i> = − 0.452) between baseline and end of TRE. The odds of EAH were significantly lower during TRE than baseline (week 1 OR: 0.48, 95% CI 0.32–0.71; week 4 OR: 0.46, 95% CI 0.29–0.71, both <i>p</i> &lt; 0.001). Compared to baseline, EAH decreased during fasting and the first 4&#xa0;h of the eating window (<i>p</i> = 0.002–0.033), but not later in the eating window (<i>p</i> = 0.579–0.763).</p> Conclusions <p>A brief TRE intervention reduced emotional eating and visceral fat in emerging adult women. However, results are preliminary and caution is still warranted when implementing restrictive interventions in this population.</p> <p>Clinicaltrials.gov identifier: NCT06145009, submitted 10/17/2023.</p> <p>Level III: Evidence obtained from well-designed cohort or case–control analytic studies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Four-week time restricted eating intervention is associated with improvements in cardiometabolic risk factors and dysregulated eating among emerging adult women: a single-armed trial

  • Diane Vizthum,
  • Carrie P. Earthman,
  • Freda Patterson,
  • Melissa M. Melough,
  • Kelly C. Allison,
  • Carly R. Pacanowski

摘要

Purpose

Time restricted eating (TRE) improves cardiometabolic (CM) health. However, TRE’s usefulness as a preventative intervention, particularly among women at risk for dysregulated eating is unknown. This single-arm study examined the impact of a 4-week TRE intervention on eating behaviors, body composition, and dietary intake in women at risk for dysregulated eating.

Methods

36 emerging adult women with eating windows ≥ 12 h and moderate–high dietary restraint completed 1 baseline week and 4 weeks of TRE (10 h eating window ending by 8 pm). Participants completed the Dutch Eating Behavior Questionnaire, 3-day food logs, anthropometric measurements, and DXA scans at baseline and post-intervention. Ecological momentary assessments (EMA) were administered 5x/day during baseline and weeks 1 and 4 of TRE to assess eating in the absence of hunger (EAH).

Results

Adherence with TRE and EMA was above 85%. Significant decreases occurred in emotional eating (p = 0.009, Cohen’s d = − 0.470), caloric intake (p < 0.001, Cohen’s d = − 0.750), body weight (p < 0.001, Cohen’s d = − 0.649), and visceral fat (p = 0.026, Cohen’s d = − 0.452) between baseline and end of TRE. The odds of EAH were significantly lower during TRE than baseline (week 1 OR: 0.48, 95% CI 0.32–0.71; week 4 OR: 0.46, 95% CI 0.29–0.71, both p < 0.001). Compared to baseline, EAH decreased during fasting and the first 4 h of the eating window (p = 0.002–0.033), but not later in the eating window (p = 0.579–0.763).

Conclusions

A brief TRE intervention reduced emotional eating and visceral fat in emerging adult women. However, results are preliminary and caution is still warranted when implementing restrictive interventions in this population.

Clinicaltrials.gov identifier: NCT06145009, submitted 10/17/2023.

Level III: Evidence obtained from well-designed cohort or case–control analytic studies.